ANABOLIC EFFECT OF LNA043, A NOVEL DISEASE-MODIFYING OSTEOARTHRITIS DRUG CANDIDATE: RESULTS FROM AN IMAGING-BASED PROOF-OF-CONCEPT TRIAL IN PATIENTS WITH FOCAL ARTICULAR CARTILAGE LESIONS

TRATTNIG, S; C SCOTTI; D LAURENT; V JURAS; S HACKER; B COLE; Libor PAŠA; R LEHOVEC; P SZOMOLANYI; E RAITHEL; F SAXER; J PRAESTGAARD; Gamba F LA; JL JIMENEZ; DS RAMOS; R ROUBENOFF and M SCHIEKER. ANABOLIC EFFECT OF LNA043, A NOVEL DISEASE-MODIFYING OSTEOARTHRITIS DRUG CANDIDATE: RESULTS FROM AN IMAGING-BASED PROOF-OF-CONCEPT TRIAL IN PATIENTS WITH FOCAL ARTICULAR CARTILAGE LESIONS. 2021. Available from: https://doi.org/10.1136/annrheumdis-2021-eular.447.

Basic information

Original name

ANABOLIC EFFECT OF LNA043, A NOVEL DISEASE-MODIFYING OSTEOARTHRITIS DRUG CANDIDATE: RESULTS FROM AN IMAGING-BASED PROOF-OF-CONCEPT TRIAL IN PATIENTS WITH FOCAL ARTICULAR CARTILAGE LESIONS

Authors

TRATTNIG, S; C SCOTTI; D LAURENT; V JURAS; S HACKER; B COLE; Libor PAŠA; R LEHOVEC; P SZOMOLANYI; E RAITHEL; F SAXER; J PRAESTGAARD; Gamba F LA; JL JIMENEZ; DS RAMOS; R ROUBENOFF and M SCHIEKER

Edition

2021

---

Other information

Language

English

Type of outcome

Conference abstract

Confidentiality degree

is not subject to a state or trade secret

Organization unit

Faculty of Medicine

DOI

https://doi.org/10.1136/annrheumdis-2021-eular.447

UT WoS

000692629300570